Cargando…
Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy
Recently, the emergence of immunotherapy has revolutionized traditional tumour treatment. However, effective treatments for patients exhibiting αPD-1 resistance are still lacking. In our study, a combination of cytosine–phosphate–guanine oligodeoxynucleotides (CpG-ODNs), anti-OX40 and cyclic guanosi...
Autores principales: | Cai, Luya, Du, Xuedan, Zhang, Cheng, Yu, Shanshan, Liu, Lixiao, Zhao, Jinduo, Zhao, Ye, Zhang, Chunhong, Wu, Jinting, Wang, Bin, Chen, Yingyu, Su, Xiaoping, Yan, Xiaojian, Li, Wenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188536/ https://www.ncbi.nlm.nih.gov/pubmed/34731284 http://dx.doi.org/10.1007/s00262-021-03095-z |
Ejemplares similares
-
Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4(+) T cells in melanomas
por: Du, Xuedan, et al.
Publicado: (2022) -
cGAMP the travelling messenger
por: Blest, Henry T. W., et al.
Publicado: (2023) -
Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
por: He, Yanpu, et al.
Publicado: (2020) -
The Signaling Pathway That cGAMP Riboswitches Found: Analysis and Application of Riboswitches to Study cGAMP Signaling in Geobacter sulfurreducens
por: Tan, Zhesen, et al.
Publicado: (2022) -
Human SLC46A2 Is the Dominant cGAMP Importer in Extracellular
cGAMP-Sensing Macrophages and Monocytes
por: Cordova, Anthony F., et al.
Publicado: (2021)